Microbiology & Immunology Research Program

The microbiology and immunology research program was launched in 2018, with a state-of-the-art immunology unit, then expanded its scope in 2021, to include microbiology and immunology research.

Our research program aims to play its role, within the hospital’s endeavor to eradicate childhood cancer. To achieve this goal, we conduct experimental research that precisely leverages the human immune system and the resident human microbiota to improve patient survival, ameliorate the outcome of cancer therapy, overcome therapy complications, and eventually eradicate childhood cancer.